The Microphysiological System Market growth is driven by the increasing demand for more reliable and human-relevant testing models in drug development. Traditional methods often fail to accurately predict human responses, leading to high failure rates in clinical trials. Microphysiological systems address this challenge by providing more accurate simulations of human physiology. The growing focus on improving drug safety and efficacy is encouraging the adoption of these systems across the pharmaceutical industry.

In addition, the integration of artificial intelligence and data analytics is enhancing the capabilities of microphysiological systems. These technologies enable better data interpretation and predictive modeling, improving research outcomes. The rise of personalized medicine is also driving demand, as these systems can be customized to reflect individual patient conditions. Continuous innovation and increasing research funding are expected to further accelerate market growth.

FAQ

Q1. What drives market growth?
Need for accurate drug testing models.

Q2. What are key trends?
AI integration and personalized medicine.